热门资讯> 正文
NRX Pharmaceuticals Secures Non-Binding Debt Financing Agreements for Ketamine Clinics
2024-08-26 21:02
09:02 AM EDT, 08/26/2024 (MT Newswires) -- NRX Pharmaceuticals' (NRXP) HOPE Therapeutics subsidiary said Monday it has signed a non-binding agreement for $30 million in debt financing for its first interventional psychiatric clinics using the drug ketamine.
The company also signed a non-binding agreement for $10 million worth of financing for five existing clinics in the western US.
The company said it has been offered enough financing to build a network of clinics in the US, the UK and France that could generate annual revenue of more than $100 million.
Price: 2.0500, Change: -0.04, Percent Change: -1.91
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
